Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
As of January 2025 Novo Nordisk has a market cap of ₹32.275 Trillion. This makes Novo Nordisk the world's 24th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 14th, 2025 the market cap of Novo Nordisk was reported to be: